Literature DB >> 11290536

Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation.

E Pinter1, J Haigh, A Nagy, J A Madri.   

Abstract

Major congenital malformations, including those affecting the cardiovascular system, remain the leading cause of mortality and morbidity in infants of diabetic mothers. Interestingly, targeted mutations of several genes (including VEGF and VEGF receptors) and many teratogenic agents (including excess D-glucose) that give rise to embryonic lethal phenotypes during organogenesis are associated with a failure in the formation and/or maintenance of a functional vitelline circulation. Given the similarities in the pathology of the abnormal vitelline circulation in many of these conditions, we hypothesized that the hyperglycemic insult present in diabetes could cause the resultant abnormalities in the vitelline circulation by affecting VEGF/VEGF receptor signaling pathway(s). In this study we report that hyperglycemic insult results in reduced levels of VEGF-A in the conceptus, which in turn, leads to abnormal VEGF receptor signaling, ultimately resulting in embryonic (vitelline) vasculopathy. These findings and our observation that addition of exogenous rVEGF-A(165) within a defined concentration range blunts the hyperglycemia-induced vasculopathy in the conceptus support the concept that VEGF levels can be modulated by glucose levels. In addition, these findings may ultimately lead to novel therapeutic approaches for the treatment of selected congenital cardiovascular abnormalities associated with diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290536      PMCID: PMC1891927          DOI: 10.1016/S0002-9440(10)64069-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  Effects of diabetic pregnancy on the fetus and newborn.

Authors:  R Schwartz; K A Teramo
Journal:  Semin Perinatol       Date:  2000-04       Impact factor: 3.300

2.  Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.

Authors:  N Ilan; L Cheung; E Pinter; J A Madri
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 3.  Whole-embryo culture and the study of mammalian embryos during organogenesis.

Authors:  D A New
Journal:  Biol Rev Camb Philos Soc       Date:  1978-02

4.  Multiple developmental roles of VEGF suggested by a LacZ-tagged allele.

Authors:  L Miquerol; M Gertsenstein; K Harpal; J Rossant; A Nagy
Journal:  Dev Biol       Date:  1999-08-15       Impact factor: 3.582

5.  VEGF regulates cell behavior during vasculogenesis.

Authors:  C J Drake; A LaRue; N Ferrara; C D Little
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

6.  Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells.

Authors:  M Hidaka; W L Stanford; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 7.  Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.

Authors:  E Duh; L P Aiello
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

8.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

9.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin.

Authors:  N Ilan; S Mahooti; D L Rimm; J A Madri
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

10.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.

Authors:  L Miquerol; B L Langille; A Nagy
Journal:  Development       Date:  2000-09       Impact factor: 6.868

View more
  21 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

3.  Role of HIF-1α in maternal hyperglycemia-induced embryonic vasculopathy.

Authors:  Peixin Yang; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 4.  New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.

Authors:  Daoyin Dong; E Albert Reece; Xue Lin; Yanqing Wu; Natalia AriasVillela; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2015-09-30       Impact factor: 8.661

5.  VEGF-A and Semaphorin3A: modulators of vascular sympathetic innervation.

Authors:  Jennifer B Long; Steven M Jay; Steven S Segal; Joseph A Madri
Journal:  Dev Biol       Date:  2009-07-23       Impact factor: 3.582

6.  Vascular remodeling of the mouse yolk sac requires hemodynamic force.

Authors:  Jennifer L Lucitti; Elizabeth A V Jones; Chengqun Huang; Ju Chen; Scott E Fraser; Mary E Dickinson
Journal:  Development       Date:  2007-09       Impact factor: 6.868

7.  Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats.

Authors:  Parri Wentzel; Mattias Gäreskog; Ulf J Eriksson
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

Review 8.  Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes.

Authors:  Monica E Bianco; Jami L Josefson
Journal:  Curr Diab Rep       Date:  2019-11-21       Impact factor: 4.810

Review 9.  The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis.

Authors:  A Aceti; S Santhakumaran; K M Logan; L H Philipps; E Prior; C Gale; M J Hyde; N Modi
Journal:  Diabetologia       Date:  2012-09-05       Impact factor: 10.122

10.  Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defects.

Authors:  Anjali K Nath; Michael Krauthammer; Puyao Li; Eugene Davidov; Lucas C Butler; Joshua Copel; Mikko Katajamaa; Matej Oresic; Irina Buhimschi; Catalin Buhimschi; Michael Snyder; Joseph A Madri
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.